ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 125 filers reported holding ABCELLERA BIOLOGICS INC in Q4 2021. The put-call ratio across all filers is 0.67 and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $48,995 | -28.8% | 10,651 | 0.0% | 0.00% | -33.3% |
| Q2 2023 | $68,806 | -14.3% | 10,651 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $80,309 | -25.6% | 10,651 | 0.0% | 0.00% | -40.0% |
| Q4 2022 | $107,895 | +2.8% | 10,651 | 0.0% | 0.01% | -16.7% |
| Q3 2022 | $105,000 | -7.1% | 10,651 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $113,000 | +8.7% | 10,651 | 0.0% | 0.01% | +20.0% |
| Q1 2022 | $104,000 | -31.6% | 10,651 | 0.0% | 0.01% | -28.6% |
| Q4 2021 | $152,000 | -85.0% | 10,651 | -79.0% | 0.01% | -86.3% |
| Q3 2021 | $1,014,000 | -9.0% | 50,651 | 0.0% | 0.05% | -13.6% |
| Q2 2021 | $1,114,000 | – | 50,651 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $37,320,000 | 92.58% |
| Gruss & Co., LLC | 308,570 | $3,052,000 | 26.27% |
| Founders Fund Growth Management, LLC | 407,017 | $4,025,000 | 11.55% |
| Belmont Capital, LLC | 510,000 | $5,044,000 | 5.95% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $40,599,000 | 5.05% |
| GUARDIAN CAPITAL ADVISORS LP | 3,736,414 | $40,129,000 | 5.01% |
| Intellectus Partners, LLC | 1,091,505 | $10,795,000 | 3.84% |
| ArchPoint Investors | 617,213 | $6,104,000 | 2.49% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $563,000 | 1.85% |
| Casdin Capital, LLC | 1,650,000 | $16,319,000 | 1.07% |